NR 565 Exam 1: Advanced Pharmacology Fundamentals V2
Updated and Latest Questions and Correct Answers with
Rationale
1. Which phase of pharmacokinetics involves the movement of a drug from its site of
administration into the blood?
A. Distribution
B. Metabolism
C. Excretion
D. Absorption
Ans: D
Rationale: Absorption is the first phase of pharmacokinetics where a substance enters the systemic
circulation. This process determines how soon the drug’s effects will begin based on the rate of entry.
Factors such as the route of administration and drug solubility significantly influence this movement. For
instance, intravenous administration bypasses the absorption step entirely by entering the blood directly.
Lipid-soluble drugs generally cross cell membranes more easily than water-soluble ones. Understanding
absorption is critical for selecting the appropriate dosage form for a patient.
,2. The ‘first-pass effect’ primarily occurs in which organ?
A. Kidneys
B. Small Intestine
C. Lungs
D. Liver
Ans: D
Rationale: The first-pass effect refers to the rapid hepatic inactivation of certain oral drugs. After being
absorbed from the gastrointestinal tract, drugs are carried directly to the liver via the hepatic portal vein.
If the liver’s capacity to metabolize the drug is high, the drug can be completely inactivated. This explains
why some medications cannot be given orally and must be administered parenterally. Nitroglycerin is a
classic example of a drug with a high first-pass effect. Clinicians must account for this phenomenon when
calculating dosages for oral versus intravenous routes.
3. Which plasma protein is most commonly responsible for binding drugs in the
bloodstream?
A. Hemoglobin
B. Gamma globulin
C. Fibrinogen
D. Albumin
Ans: D
,Rationale: Albumin is the most prevalent protein in the plasma and serves as a major carrier for many
drugs. Only drug molecules that are not bound to albumin are considered free and pharmacologically
active. When a drug is bound to protein, it is too large to leave the capillaries and reach its target site.
This binding is usually reversible and exists in a state of equilibrium. Malnutrition or liver disease can
lead to low albumin levels, increasing the risk of drug toxicity. Prescribers must monitor patients with
low protein levels closely for intensified drug effects.
4. A drug that activates a receptor to produce a biological response is known as a(n):
A. Antagonist
B. Inverse inhibitor
C. Agonist
D. Partial blocker
Ans: C
Rationale: Agonists are molecules that mimic the action of endogenous regulatory molecules by binding
to receptors. They possess both high affinity for the receptor and high intrinsic activity to trigger a
response. By binding to the receptor, they can accelerate or slow down normal physiological processes.
Some agonists are more potent than others, requiring a smaller dose to achieve a maximal effect. Many
common medications, such as insulin and morphine, function as agonists within the body. Understanding
agonist behavior helps clinicians predict how a drug will alter a patient’s physiology.
, 5. Which schedule of controlled substances has the highest potential for abuse while still
having an accepted medical use?
A. Schedule I
B. Schedule IV
C. Schedule III
D. Schedule II
Ans: D
Rationale: Schedule II drugs are classified as having a high potential for abuse that may lead to severe
psychological or physical dependence. Unlike Schedule I drugs, they have currently accepted medical
uses in treatment in the United States. Examples include morphine, oxycodone, and various
amphetamines used for ADHD. Prescriptions for these substances generally cannot be refilled and must
be written or e-prescribed according to strict rules. Schedule I substances are excluded because they are
considered to have no accepted medical use and high abuse potential. APRNs must be well-versed in
these federal regulations to maintain legal compliance in their practice.
Updated and Latest Questions and Correct Answers with
Rationale
1. Which phase of pharmacokinetics involves the movement of a drug from its site of
administration into the blood?
A. Distribution
B. Metabolism
C. Excretion
D. Absorption
Ans: D
Rationale: Absorption is the first phase of pharmacokinetics where a substance enters the systemic
circulation. This process determines how soon the drug’s effects will begin based on the rate of entry.
Factors such as the route of administration and drug solubility significantly influence this movement. For
instance, intravenous administration bypasses the absorption step entirely by entering the blood directly.
Lipid-soluble drugs generally cross cell membranes more easily than water-soluble ones. Understanding
absorption is critical for selecting the appropriate dosage form for a patient.
,2. The ‘first-pass effect’ primarily occurs in which organ?
A. Kidneys
B. Small Intestine
C. Lungs
D. Liver
Ans: D
Rationale: The first-pass effect refers to the rapid hepatic inactivation of certain oral drugs. After being
absorbed from the gastrointestinal tract, drugs are carried directly to the liver via the hepatic portal vein.
If the liver’s capacity to metabolize the drug is high, the drug can be completely inactivated. This explains
why some medications cannot be given orally and must be administered parenterally. Nitroglycerin is a
classic example of a drug with a high first-pass effect. Clinicians must account for this phenomenon when
calculating dosages for oral versus intravenous routes.
3. Which plasma protein is most commonly responsible for binding drugs in the
bloodstream?
A. Hemoglobin
B. Gamma globulin
C. Fibrinogen
D. Albumin
Ans: D
,Rationale: Albumin is the most prevalent protein in the plasma and serves as a major carrier for many
drugs. Only drug molecules that are not bound to albumin are considered free and pharmacologically
active. When a drug is bound to protein, it is too large to leave the capillaries and reach its target site.
This binding is usually reversible and exists in a state of equilibrium. Malnutrition or liver disease can
lead to low albumin levels, increasing the risk of drug toxicity. Prescribers must monitor patients with
low protein levels closely for intensified drug effects.
4. A drug that activates a receptor to produce a biological response is known as a(n):
A. Antagonist
B. Inverse inhibitor
C. Agonist
D. Partial blocker
Ans: C
Rationale: Agonists are molecules that mimic the action of endogenous regulatory molecules by binding
to receptors. They possess both high affinity for the receptor and high intrinsic activity to trigger a
response. By binding to the receptor, they can accelerate or slow down normal physiological processes.
Some agonists are more potent than others, requiring a smaller dose to achieve a maximal effect. Many
common medications, such as insulin and morphine, function as agonists within the body. Understanding
agonist behavior helps clinicians predict how a drug will alter a patient’s physiology.
, 5. Which schedule of controlled substances has the highest potential for abuse while still
having an accepted medical use?
A. Schedule I
B. Schedule IV
C. Schedule III
D. Schedule II
Ans: D
Rationale: Schedule II drugs are classified as having a high potential for abuse that may lead to severe
psychological or physical dependence. Unlike Schedule I drugs, they have currently accepted medical
uses in treatment in the United States. Examples include morphine, oxycodone, and various
amphetamines used for ADHD. Prescriptions for these substances generally cannot be refilled and must
be written or e-prescribed according to strict rules. Schedule I substances are excluded because they are
considered to have no accepted medical use and high abuse potential. APRNs must be well-versed in
these federal regulations to maintain legal compliance in their practice.
